SPDR S&P Biotech ETF (NYSEARCA:XBI) Shares Acquired by Envestnet Asset Management Inc.

Envestnet Asset Management Inc. lifted its holdings in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 12.5% during the 2nd quarter, Holdings Channel.com reports. The fund owned 186,400 shares of the exchange traded fund’s stock after buying an additional 20,685 shares during the period. Envestnet Asset Management Inc.’s holdings in SPDR S&P Biotech ETF were worth $17,281,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also made changes to their positions in XBI. Avoro Capital Advisors LLC acquired a new stake in shares of SPDR S&P Biotech ETF during the 4th quarter worth about $396,844,000. Healthcare of Ontario Pension Plan Trust Fund raised its position in shares of SPDR S&P Biotech ETF by 30.3% during the 1st quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 3,136,000 shares of the exchange traded fund’s stock worth $297,575,000 after acquiring an additional 730,000 shares in the last quarter. Mirae Asset Securities USA Inc. acquired a new stake in shares of SPDR S&P Biotech ETF during the 2nd quarter worth about $55,626,000. Jane Street Group LLC raised its position in shares of SPDR S&P Biotech ETF by 68.7% during the 1st quarter. Jane Street Group LLC now owns 961,082 shares of the exchange traded fund’s stock worth $91,197,000 after acquiring an additional 391,333 shares in the last quarter. Finally, Baymount Management LP acquired a new stake in shares of SPDR S&P Biotech ETF during the 1st quarter worth about $34,160,000.

SPDR S&P Biotech ETF Stock Performance

Shares of NYSEARCA XBI opened at $99.19 on Tuesday. The firm has a market capitalization of $7.56 billion, a PE ratio of 11.47 and a beta of 1.11. SPDR S&P Biotech ETF has a fifty-two week low of $63.80 and a fifty-two week high of $103.52. The stock’s 50-day simple moving average is $99.01 and its 200-day simple moving average is $93.91.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.